Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 14.52 is 41% above its 5-year average of 10.29, around the middle of its 5-year range (0.53–45.36).
As of the fiscal period ended Tuesday, June 30, 2026. 201.36% above its 12-month average of 4.82.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.52.
QUICK RATIO (ACID-TEST)
14.52
QUICK RATIO (ACID-TEST) AVG TTM
4.82
QUICK RATIO (ACID-TEST) AVG 3Y
5.92
QUICK RATIO (ACID-TEST) AVG 5Y
10.29
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+201.36%
CURRENT VS 3Y AVG
+145.26%
CURRENT VS 5Y AVG
+41.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+333.40%
vs the sector median at left
Quince Therapeutics, Inc.
Market Cap
$7.56M
Quick Ratio (Acid-Test)
14.52
TTM Avg
4.82
3Y Avg
5.92
5Y Avg
10.29
Market Cap
$7.30M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$7.65M
Quick Ratio (Acid-Test)
7.10
TTM Avg
3.48
3Y Avg
3.44
5Y Avg
4.75
Market Cap
$7.76M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$7.36M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$7.29M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$7.92M
Quick Ratio (Acid-Test)
0.43
TTM Avg
1.44
3Y Avg
2.56
5Y Avg
3.54
Market Cap
$7.18M
Quick Ratio (Acid-Test)
2.63
TTM Avg
4.46
3Y Avg
3.65
5Y Avg
4.69
Market Cap
$7.91M
Quick Ratio (Acid-Test)
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | $7.56M | 14.52 | 4.82 | 5.92 | 10.29 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.30M | 0.18 | 0.90 | 2.06 | 1.76 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.65M | 7.10 | 3.48 | 3.44 | 4.75 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.76M | 5.86 | 2.71 | 2.06 | 3.31 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.36M | 1.37 | 3.92 | 4.12 | 3.73 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.29M | 0.95 | 9.81 | 5.30 | 4.51 |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | 0.43 | 1.44 | 2.56 | 3.54 |
| Longeveron Inc. (LGVN)vs › | $7.18M | 2.63 | 4.46 | 3.65 | 4.69 |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.91M | 13.55 | 6.32 | 6.80 | 6.83 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.89M | 45.95 | 58.73 | 40.89 | 40.89 |
Quick Ratio
14.52
Excludes inventory
Current Ratio
14.52
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 14.52 |
| 2026-03-31 | 2.92 |
| 2025-12-31 | 0.53 |
| 2025-09-30 | 1.12 |
| 2025-06-30 | 5.00 |
| 2025-03-31 | 4.05 |
| 2024-12-31 | 6.05 |
| 2024-09-30 | 9.53 |
| 2024-06-30 | 6.15 |
| 2024-03-31 | 7.16 |
| 2023-12-31 | 8.09 |
| 2023-09-30 | 37.80 |
| 2023-06-30 | 45.36 |
| 2023-03-31 | 29.69 |
| 2022-12-31 | 30.55 |
| 2022-09-30 | 19.87 |
| 2022-06-30 | 16.70 |
| 2022-03-31 | 9.92 |
| 2021-12-31 | 7.85 |
| 2021-09-30 | 8.44 |
| 2021-06-30 | 7.33 |
| 2021-03-31 | 8.39 |
| 2020-12-31 | 8.11 |
| 2020-09-30 | 8.71 |
| 2020-06-30 | 11.07 |
| 2020-03-31 | 12.86 |
| 2019-12-31 | 11.93 |
| 2019-09-30 | 20.30 |
| 2019-06-30 | 19.02 |
| 2019-03-31 | 15.91 |
| 2018-12-31 | 49.82 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
